SCHEMBL20134480

SCHEMBL20134480

CC(C)(C)c1cc(O)cc(O)c1C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
ALOX15 P16050 6/20 0.52
TYR P14679 2/20 0.52
LMNA P02545 2/20 0.52
CYP2C9 P11712 2/20 0.52
HSD17B10 Q99714 2/20 0.52
HTT P42858 2/20 0.52
NR1I2 O75469 1/20 0.52
MIF P14174 1/20 0.52
NFE2L2 Q16236 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
CYP1A2 P05177 2/20 0.50
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ATP2A2 P16615 1/20 0.50
ATP2A3 Q93084 1/20 0.50
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
CA2 P00918 4/20 0.41
CA1 P00915 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11034207 0.87 ALDH1A1 (0.52) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL9743218 0.85 GABRA1 (0.50) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL9652141 0.80 ALDH1A1 (0.50) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL38657300 0.79 ALDH1A1 (0.60) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL28487119 0.79 ALDH1A1 (0.48) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL23387403 0.79 ALOX15 (0.45) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL176344 0.79 ALDH1A1 (0.60) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL8611108 0.78 CA2 (0.54) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL9820540 0.78 ALDH1A1 (0.59) ALDH1A1ALOX15TYRLMNACYP2C9
SCHEMBL18688896 0.77 ALDH1A1 (0.46) ALDH1A1ALOX15TYRLMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127392-A1 ECKOL DERIVATIVES, METHODS OF SYNTHESIS AND USES THEREOF Phloronol, Inc. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127392-A1 ECKOL DERIVATIVES, METHODS OF SYNTHESIS AND USES THEREOF MGLL, PNLIP, ECHS1 ALDH1A1 1648/4885ALOX15 54/4885TYR 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.